Clinical Trials List
2020-02-01 - 2026-12-31
Phase II/III
Recruiting5
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Ann-Lii Cheng Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- Hsiang-Fong Kao Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
- 呂理駿 Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- 陳國興 Division of Hematology & Oncology
- YU-YUN SHAO Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
5 participants
-
Global
850 participants
